Obesity is not associated with contrast nephropathy

被引:0
|
作者
Jaipaul, Navin [1 ]
Manalo, Rendell [2 ]
Sadjadi, Seyed-Ali [1 ]
McMillan, James [1 ]
机构
[1] VA Loma Linda Healthcare Syst, Nephrol Sect, Loma Linda, CA 92357 USA
[2] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA
关键词
obesity; contrast nephropathy; kidney injury;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Exposure to radiocontrast media may result in acute kidney injury (AKI) or traditionally defined contrast nephropathy (CN), both of which may lead to increased morbidity and mortality. The pathogenesis of both these variants of contrast-induced nephropathy (CIN) may involve inflammatory mediators that lead to renal impairment. A link between obesity and inflammation has been clearly established, but whether obesity is independently associated with CIN is unknown. Objective: To determine whether obesity, when stratified by body mass index (BMI), is a risk factor for CIN in a large and hemodynamically stable population of hospitalized United States veterans. Design: Retrospective chart review. Measurements: Presence or absence of AKI or CN after intravenous radiocontrast administration and comparison of patient characteristics between those with versus without AKI or CN. Results: The overall prevalence of AKI and CN was 16.1% and 12.6%, respectively. Patients with AKI or CN were comparable to those without radiocontrast injury, except that affected patients tended to be older and diabetic. When stratified by BMI, obesity was not found to be associated with the development of AKI or CN after exposure to radiocontrast. Conclusion: Obesity does not appear to be an independent risk factor for AKI or CN after exposure to radiocontrast.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 50 条
  • [21] CONTRAST NEPHROPATHY
    THOMSEN, HS
    CURRENT OPINION IN RADIOLOGY, 1990, 2 (06) : 793 - 802
  • [22] Prevention and treatment of contrast-associated nephropathy in interventional cardiology
    Caixeta A.
    Nikolsky E.
    Mehran R.
    Current Cardiology Reports, 2009, 11 (5) : 377 - 383
  • [23] Evaluation of two methods to avoid contrast associated nephropathy.
    Diez, T
    Bagilet, D
    Ramos, M
    Jolly, H
    Diab, M
    Marcucci, R
    Rojo, L
    MEDICINA-BUENOS AIRES, 1999, 59 (01) : 55 - 58
  • [24] Contrast-associated nephropathy: Does the route of administration matter?
    Mao, Catherine
    Chacko, Bobby
    CLINICAL NEPHROLOGY, 2018, 90 (03) : 161 - 164
  • [25] EXPERIMENTAL CONTRAST-ASSOCIATED NEPHROPATHY AND ITS CLINICAL IMPLICATIONS
    PORTER, GA
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (14): : F18 - F22
  • [26] HYPERHOMOCYSTEINEMIA; ANOTHER RISK FACTOR ASSOCIATED WITH CONTRAST MEDIA INDUCED NEPHROPATHY
    Yoon, Hyuck
    Shin, Hong-won
    Son, Ji-hyun
    Park, Hyoung-Seob
    Cho, Yun-Kyeong
    Han, Chunduk
    Kim, Hyungseop
    Nam, Chang-Wook
    Hur, Seung-Ho
    Kim, Yoon-Nyun
    Kim, Kwon-Bae
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [27] RISK FACTORS ASSOCIATED WITH CONTRAST-INDUCED NEPHROPATHY IN TRAUMA PATIENTS
    Jones, Lauren
    Bethea, J.
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U191 - U191
  • [28] Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?
    Rachoin, Jean-Sebastien
    Wolfe, Yanika
    Patel, Sharad
    Cerceo, Elizabeth
    RENAL FAILURE, 2021, 43 (01) : 1311 - 1321
  • [29] CONTRAST NEPHROPATHY IN PPCI
    Littlewood, Simon
    Mota, Paula
    HEART, 2022, 108 : A48 - A48
  • [30] CONTRAST INDUCED NEPHROPATHY
    Meriam, Hajji
    Hela, Jebali
    Khadija, Mzoughi
    Ihssen, Zairi
    Sondes, Kraiem
    Rania, Kheder
    Lamia, Rais
    Fethi, Ben Hamida
    Karim, Zouaghi Mohammed
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32